Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2011-07-29

Clinical Trial Update: Probiotics as a Novel Approach to Modulate Gut Hormone Secretion and Risk Factors of Type 2 Diabetes and Complications [Phase 1, Phase 2]

View source ↗

Summary

This update describes Phase 1/Phase 2 clinical trials evaluating probiotic strategies to modulate gut hormone secretion. The studies target obesity and Type 2 d…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: German Diabetes Center | Conditions: Obesity, Type 2 Diabetes | Phase 1, Phase 2 | Status: UNKNOWN